500 related articles for article (PubMed ID: 32534688)
1. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
2. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
3. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
[No Abstract] [Full Text] [Related]
4. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
Kamp TJ; Hamdan MH; January CT
J Am Heart Assoc; 2020 Jun; 9(12):e016887. PubMed ID: 32463308
[No Abstract] [Full Text] [Related]
5. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
6. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
7. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
Naksuk N; Lazar S; Peeraphatdit TB
Eur Heart J Acute Cardiovasc Care; 2020 Apr; 9(3):215-221. PubMed ID: 32372695
[TBL] [Abstract][Full Text] [Related]
8. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
Keshtkar-Jahromi M; Bavari S
Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
[No Abstract] [Full Text] [Related]
9. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Juurlink DN
CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
[No Abstract] [Full Text] [Related]
10. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
11. [Potential harms associated with 4-aminoquinoline treatment].
Svensson M
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
[TBL] [Abstract][Full Text] [Related]
12. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
13. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
Lentini G; Cavalluzzi MM; Habtemariam S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
[TBL] [Abstract][Full Text] [Related]
14. Living evidence in response to controversies about the use of antimalarials in COVID-19.
Santillán-García A; Bravo-Jeria R; Verdugo-Paiva F; Rada G
Rev Esp Cardiol (Engl Ed); 2020 Aug; 73(8):693-694. PubMed ID: 32536565
[No Abstract] [Full Text] [Related]
15. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
16. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
White CM; Hernandez AV
J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
[No Abstract] [Full Text] [Related]
17. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
Defoort-Dhellemmes S
J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
[No Abstract] [Full Text] [Related]
18. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
19. Safety fears over drug hyped to treat the coronavirus spark global confusion.
Ledford H
Nature; 2020 Jun; 582(7810):18-19. PubMed ID: 32488162
[No Abstract] [Full Text] [Related]
20. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
